Global Continuous Renal Replacement Therapy Market - 2024 -2031
Continuous Renal Replacement Therapy Market Size
Global continuous renal replacement therapy market reached US$ million in 2023 and is expected to reach US$ million by 2031, growing at a high CAGR during the forecast period 2024-2031.
Continuous Renal Replacement Therapy (CRRT) is a medical therapy used to manage acute kidney injury and severe kidney dysfunction in critically ill patients. Unlike traditional intermittent hemodialysis, CRRT is a continuous process that operates over an extended period, typically 24 hours a day, providing gradual removal of fluid, electrolytes and waste products from the blood.
CRRT is primarily utilized in intensive care units (ICUs) for patients who are hemodynamically unstable or unable to tolerate the rapid fluid and solute shifts associated with intermittent hemodialysis. It offers a gentler approach to renal replacement therapy, allowing for more gradual correction of fluid and electrolyte imbalances while minimizing hemodynamic instability.
The CRRT process involves the continuous circulation of the patient's blood through a specialized extracorporeal circuit that includes a hemofilter or dialyzer. Blood flows from the patient through vascular access, usually achieved through a central venous catheter into the CRRT machine where it passes through the filter or dialyzer. Here, excess fluid, electrolytes and waste products are removed from the blood, while essential solutes are maintained or supplemented as needed. The filtered or dialyzed blood is then returned to the patient, completing the circuit.
Continuous Renal Replacement Therapy Market Dynamics
Drivers
Rising advancements in continuous renal replacement therapy machines
The rising advancements in continuous renal replacement therapy machines are expected to drive the market over the forecast period. Advancements in CRRT machine technology lead to improved efficiency in fluid and solute removal by allowing for more effective treatment of patients with acute kidney injury and other renal conditions. Enhanced performance translates to better patient outcomes and reduced treatment times, thereby driving market demand.
For instance, on May 25, 2021, Baxter International Inc. launched PrisMax 2, the latest version of the company’s next-generation platform. PrisMax 2 is designed to help simplify the delivery of continuous renal replacement therapy (CRRT) while providing hospitals the flexibility to meet the unique demands of the intensive care unit (ICU). PrisMax 2 will soon be available in more than 20 countries across the United States and Europe.
Additionally, on Dec. 8, 2020, Medtronic plc launched the Carpediem Cardio-Renal Pediatric Dialysis Emergency Machine followed by U.S. Food and Drug Administration's (FDA) marketing authorization, the first Carpediem systems in the United States were successfully installed and are in use at Cincinnati Children's Hospital Medical Center. The first-of-its-kind Carpediem system is indicated for use in acute kidney injury or fluid-overloaded patients requiring hemodialysis or hemofiltration therapy. It is intended to provide continuous renal replacement therapy (CRRT) to patients weighing between 2.5 and 10 kilograms.
Advancements in CRRT machine design have led to the development of more compact and portable models. These portable CRRT machines offer greater flexibility in deployment, allowing for use in various clinical settings, including ICUs, ambulatory care units and even home settings. The increased accessibility and versatility of portable CRRT machines contribute to market expansion.
Due to the various advantages offered by CRRT machines, many manufacturing companies and institutes are focussing on developing these machines. For instance, on March 14, 2024, On World Kidney Day, Travancore Medicity unveiled Kollam’s inaugural Continuous Renal Replacement Therapy (CRRT) machine, marking a significant milestone in the healthcare journey. In critically ill kidney patients, the CRRT machine helps to control blood pressure, maintain fluid balance in the body and improve the chances of survival.
Further, the increasing prevalence of renal injuries, rising aging population, increasing awareness about the CRRT and advancements in the development of novel products for the CRRT procedure are the factors expected to drive the market over the forecast period.
Restraints
Factors such as the high cost associated with CRRT machines, systems and consumables, risks and complications associated with the CPPT therapy and availability of alternative dialysis methods are the factors expected to hamper the market.
Continuous Renal Replacement Therapy Market Segment Analysis
The global continuous renal replacement therapy market is segmented based on product type, modality, end-user and region.
The CRRT machines and systems segment accounted for approximately 43.7% of the continuous renal replacement therapy market share
The CRRT machines and systems segment is expected to hold the largest market share over the forecast period. Each CRRT modality, such as Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis and Continuous Venovenous Hemodiafiltration, offers unique mechanisms for solute clearance and fluid removal. Clinicians can select the most appropriate modality based on the patient's clinical condition, fluid status, metabolic needs and hemodynamic stability, allowing for personalized treatment approaches.
For instance, on August 3, 2023, Quanta Dialysis Technologies received U.S. Food and Drug Administration (FDA) 510(k) clearance for an expanded indication of the Quanta Dialysis System, a compact and easy-to-use hemodialysis device for two modalities of continuous renal replacement therapy (CRRT): continuous venovenous hemodialysis (CVVHD) and slow continuous ultrafiltration (SCUF). Under the new 510(k), the Quanta Dialysis System is the only dialysis device FDA-cleared to provide intermittent hemodialysis (IHD), sustained low-efficiency dialysis (SLED) or bagless CRRT which creates dialysate on demand all in a single machine.
CRRT machines provide continuous renal support over extended periods, typically 24 hours a day, ensuring sustained removal of uremic toxins, electrolytes, and excess fluid. This continuous clearance offers more effective control of fluid overload, metabolic imbalances and uremia, leading to improved patient outcomes compared to intermittent therapies. CRRT machines and systems are designed for use in intensive care unit (ICU) settings, where critically ill patients require close monitoring and complex renal support. These systems are equipped with features such as integration with patient monitors, alarms for early detection of complications and compatibility with ICU equipment by facilitating seamless integration into the clinical workflow.
Continuous Renal Replacement Therapy Market Geographical Share
North America accounted for approximately 41.6% of the market share
North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and well-established healthcare infrastructure. North America especially the United States is a well-known hub for its strong presence of major players such as pharmaceutical companies and medical device companies. This presence of major players in the region expands the continuous renal replacement therapy market by focusing on the development of various CRRT accessories and other CRRT products in the market.
For instance, on April 05, 2022, Baxter International Inc. cleared the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ST Set used in continuous renal replacement therapy (CRRT). The ST Set is a pre-connected, disposable, extracorporeal (outside the body) circuit that provides blood purification through a semipermeable membrane to be used with the PrisMax or Prismaflex control units (monitors).
Additionally, the region especially the United States boasts a highly developed healthcare infrastructure, with well-equipped hospitals, advanced medical technologies and a skilled workforce. This infrastructure supports the widespread adoption and utilization of CRRT machines and systems in clinical practice.
For instance, on January 27, 2023, for critically ill patients who can no longer undergo traditional dialysis, Peconic Bay Medical Center now offers a solution. The hospital announced it now offers continuous renal replacement therapy (CRRT), a blood purification process much slower than typical dialysis, for patients experiencing a kidney injury. While a patient may undergo standard dialysis a few hours a day, CRRT runs 24 hours a day. The much slower method is also more comfortable and gentler on the body.
Continuous Renal Replacement Therapy Market Competitive Landscape
The major global players in the continuous renal replacement therapy market include Baxter International Inc., Asahi Kasei Corporation, B. Braun Medical Inc., Medtronic plc, Fresenius Medical Care AG, NxStage Medical, Inc., Infomed SA, Medica SPA, Medites Pharma spol. s.r.o. and Quanta Dialysis Technologies Inc. among others.
COVID-19 Impact Analysis on Continuous Renal Replacement Therapy Market
The COVID-19 pandemic significantly impacted the global continuous renal replacement therapy market. Acute kidney injury (AKI) is a common complication among patients with COVID-19. Continuous renal replacement therapy has been recommended to treat acute kidney injury in COVID-19 patients instead of conventional intermittent hemodialysis. Moreover, its use might have another beneficial role in stopping the progression of severe COVID-19 by removing pro-inflammatory cytokines during cytokine storm syndrome, which is postulated as the pathophysiology behind severe and critically severe cases of COVID-19.
Continuous Renal Replacement Therapy Market Segmentation Analysis
By Product Type
Target Audience 2024
Global continuous renal replacement therapy market reached US$ million in 2023 and is expected to reach US$ million by 2031, growing at a high CAGR during the forecast period 2024-2031.
Continuous Renal Replacement Therapy (CRRT) is a medical therapy used to manage acute kidney injury and severe kidney dysfunction in critically ill patients. Unlike traditional intermittent hemodialysis, CRRT is a continuous process that operates over an extended period, typically 24 hours a day, providing gradual removal of fluid, electrolytes and waste products from the blood.
CRRT is primarily utilized in intensive care units (ICUs) for patients who are hemodynamically unstable or unable to tolerate the rapid fluid and solute shifts associated with intermittent hemodialysis. It offers a gentler approach to renal replacement therapy, allowing for more gradual correction of fluid and electrolyte imbalances while minimizing hemodynamic instability.
The CRRT process involves the continuous circulation of the patient's blood through a specialized extracorporeal circuit that includes a hemofilter or dialyzer. Blood flows from the patient through vascular access, usually achieved through a central venous catheter into the CRRT machine where it passes through the filter or dialyzer. Here, excess fluid, electrolytes and waste products are removed from the blood, while essential solutes are maintained or supplemented as needed. The filtered or dialyzed blood is then returned to the patient, completing the circuit.
Continuous Renal Replacement Therapy Market Dynamics
Drivers
Rising advancements in continuous renal replacement therapy machines
The rising advancements in continuous renal replacement therapy machines are expected to drive the market over the forecast period. Advancements in CRRT machine technology lead to improved efficiency in fluid and solute removal by allowing for more effective treatment of patients with acute kidney injury and other renal conditions. Enhanced performance translates to better patient outcomes and reduced treatment times, thereby driving market demand.
For instance, on May 25, 2021, Baxter International Inc. launched PrisMax 2, the latest version of the company’s next-generation platform. PrisMax 2 is designed to help simplify the delivery of continuous renal replacement therapy (CRRT) while providing hospitals the flexibility to meet the unique demands of the intensive care unit (ICU). PrisMax 2 will soon be available in more than 20 countries across the United States and Europe.
Additionally, on Dec. 8, 2020, Medtronic plc launched the Carpediem Cardio-Renal Pediatric Dialysis Emergency Machine followed by U.S. Food and Drug Administration's (FDA) marketing authorization, the first Carpediem systems in the United States were successfully installed and are in use at Cincinnati Children's Hospital Medical Center. The first-of-its-kind Carpediem system is indicated for use in acute kidney injury or fluid-overloaded patients requiring hemodialysis or hemofiltration therapy. It is intended to provide continuous renal replacement therapy (CRRT) to patients weighing between 2.5 and 10 kilograms.
Advancements in CRRT machine design have led to the development of more compact and portable models. These portable CRRT machines offer greater flexibility in deployment, allowing for use in various clinical settings, including ICUs, ambulatory care units and even home settings. The increased accessibility and versatility of portable CRRT machines contribute to market expansion.
Due to the various advantages offered by CRRT machines, many manufacturing companies and institutes are focussing on developing these machines. For instance, on March 14, 2024, On World Kidney Day, Travancore Medicity unveiled Kollam’s inaugural Continuous Renal Replacement Therapy (CRRT) machine, marking a significant milestone in the healthcare journey. In critically ill kidney patients, the CRRT machine helps to control blood pressure, maintain fluid balance in the body and improve the chances of survival.
Further, the increasing prevalence of renal injuries, rising aging population, increasing awareness about the CRRT and advancements in the development of novel products for the CRRT procedure are the factors expected to drive the market over the forecast period.
Restraints
Factors such as the high cost associated with CRRT machines, systems and consumables, risks and complications associated with the CPPT therapy and availability of alternative dialysis methods are the factors expected to hamper the market.
Continuous Renal Replacement Therapy Market Segment Analysis
The global continuous renal replacement therapy market is segmented based on product type, modality, end-user and region.
The CRRT machines and systems segment accounted for approximately 43.7% of the continuous renal replacement therapy market share
The CRRT machines and systems segment is expected to hold the largest market share over the forecast period. Each CRRT modality, such as Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis and Continuous Venovenous Hemodiafiltration, offers unique mechanisms for solute clearance and fluid removal. Clinicians can select the most appropriate modality based on the patient's clinical condition, fluid status, metabolic needs and hemodynamic stability, allowing for personalized treatment approaches.
For instance, on August 3, 2023, Quanta Dialysis Technologies received U.S. Food and Drug Administration (FDA) 510(k) clearance for an expanded indication of the Quanta Dialysis System, a compact and easy-to-use hemodialysis device for two modalities of continuous renal replacement therapy (CRRT): continuous venovenous hemodialysis (CVVHD) and slow continuous ultrafiltration (SCUF). Under the new 510(k), the Quanta Dialysis System is the only dialysis device FDA-cleared to provide intermittent hemodialysis (IHD), sustained low-efficiency dialysis (SLED) or bagless CRRT which creates dialysate on demand all in a single machine.
CRRT machines provide continuous renal support over extended periods, typically 24 hours a day, ensuring sustained removal of uremic toxins, electrolytes, and excess fluid. This continuous clearance offers more effective control of fluid overload, metabolic imbalances and uremia, leading to improved patient outcomes compared to intermittent therapies. CRRT machines and systems are designed for use in intensive care unit (ICU) settings, where critically ill patients require close monitoring and complex renal support. These systems are equipped with features such as integration with patient monitors, alarms for early detection of complications and compatibility with ICU equipment by facilitating seamless integration into the clinical workflow.
Continuous Renal Replacement Therapy Market Geographical Share
North America accounted for approximately 41.6% of the market share
North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and well-established healthcare infrastructure. North America especially the United States is a well-known hub for its strong presence of major players such as pharmaceutical companies and medical device companies. This presence of major players in the region expands the continuous renal replacement therapy market by focusing on the development of various CRRT accessories and other CRRT products in the market.
For instance, on April 05, 2022, Baxter International Inc. cleared the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ST Set used in continuous renal replacement therapy (CRRT). The ST Set is a pre-connected, disposable, extracorporeal (outside the body) circuit that provides blood purification through a semipermeable membrane to be used with the PrisMax or Prismaflex control units (monitors).
Additionally, the region especially the United States boasts a highly developed healthcare infrastructure, with well-equipped hospitals, advanced medical technologies and a skilled workforce. This infrastructure supports the widespread adoption and utilization of CRRT machines and systems in clinical practice.
For instance, on January 27, 2023, for critically ill patients who can no longer undergo traditional dialysis, Peconic Bay Medical Center now offers a solution. The hospital announced it now offers continuous renal replacement therapy (CRRT), a blood purification process much slower than typical dialysis, for patients experiencing a kidney injury. While a patient may undergo standard dialysis a few hours a day, CRRT runs 24 hours a day. The much slower method is also more comfortable and gentler on the body.
Continuous Renal Replacement Therapy Market Competitive Landscape
The major global players in the continuous renal replacement therapy market include Baxter International Inc., Asahi Kasei Corporation, B. Braun Medical Inc., Medtronic plc, Fresenius Medical Care AG, NxStage Medical, Inc., Infomed SA, Medica SPA, Medites Pharma spol. s.r.o. and Quanta Dialysis Technologies Inc. among others.
COVID-19 Impact Analysis on Continuous Renal Replacement Therapy Market
The COVID-19 pandemic significantly impacted the global continuous renal replacement therapy market. Acute kidney injury (AKI) is a common complication among patients with COVID-19. Continuous renal replacement therapy has been recommended to treat acute kidney injury in COVID-19 patients instead of conventional intermittent hemodialysis. Moreover, its use might have another beneficial role in stopping the progression of severe COVID-19 by removing pro-inflammatory cytokines during cytokine storm syndrome, which is postulated as the pathophysiology behind severe and critically severe cases of COVID-19.
Continuous Renal Replacement Therapy Market Segmentation Analysis
By Product Type
- Consumables
- Filters
- Replacement Fluids
- Others
- CRRT Machines and Systems
- Accessories
- Catheters
- Connectors
- Monitors
- Others
- Continuous Venovenous Hemofiltration (CVVH)
- Continuous Venovenous Hemodialysis (CVVHD)
- Continuous Venovenous Hemodiafiltration (CVVHDF)
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Homecare Settings
- Others
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
- South America
- Brazil
- Argentina
- Rest of South America
- Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
- Middle East and Africa
- To visualize the global continuous renal replacement therapy market segmentation based on product type, modality, end-user and region as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development
- Excel data sheet with numerous data points of continuous renal replacement therapy market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key products of all the major players.
Target Audience 2024
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Product Type
3.2. Snippet by Modality
3.3. Snippet by End-User
3.4. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Advancements in Continuous Renal Replacement Therapy Machines
4.1.2. Restraints
4.1.2.1. High Cost Associated with CPPT
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. BY PRODUCT TYPE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Consumables*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.2.3. Filters
7.2.4. Replacement Fluids
7.2.5. Others
7.3. CRRT Machines and Systems
7.4. Accessories
7.4.1. Catheters
7.4.2. Connectors
7.4.3. Monitors
7.4.4. Others
8. BY MODALITY
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
8.1.2. Market Attractiveness Index, By Modality
8.2. Continuous Venovenous Hemofiltration (CVVH)*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Continuous Venovenous Hemodialysis (CVVHD)
8.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
9. BY END-USER
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Clinics
9.4. Ambulatory Surgical Centers
9.5. Homecare Settings
9.6. Others
10. BY REGION
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. COMPETITIVE LANDSCAPE
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. COMPANY PROFILES
12.1. Baxter International Inc.*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Asahi Kasei Corporation
12.3. B. Braun Medical Inc.
12.4. Medtronic plc
12.5. Fresenius Medical Care AG
12.6. NxStage Medical, Inc.
12.7. Infomed SA
12.8. Medica SPA
12.9. Medites Pharma spol. s.r.o.
12.10. Quanta Dialysis Technologies Inc.(*LIST NOT EXHAUSTIVE)
13. APPENDIX
13.1. About Us and Services
13.2. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Product Type
3.2. Snippet by Modality
3.3. Snippet by End-User
3.4. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Advancements in Continuous Renal Replacement Therapy Machines
4.1.2. Restraints
4.1.2.1. High Cost Associated with CPPT
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. BY PRODUCT TYPE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Consumables*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.2.3. Filters
7.2.4. Replacement Fluids
7.2.5. Others
7.3. CRRT Machines and Systems
7.4. Accessories
7.4.1. Catheters
7.4.2. Connectors
7.4.3. Monitors
7.4.4. Others
8. BY MODALITY
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
8.1.2. Market Attractiveness Index, By Modality
8.2. Continuous Venovenous Hemofiltration (CVVH)*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Continuous Venovenous Hemodialysis (CVVHD)
8.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
9. BY END-USER
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Clinics
9.4. Ambulatory Surgical Centers
9.5. Homecare Settings
9.6. Others
10. BY REGION
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. COMPETITIVE LANDSCAPE
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. COMPANY PROFILES
12.1. Baxter International Inc.*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Asahi Kasei Corporation
12.3. B. Braun Medical Inc.
12.4. Medtronic plc
12.5. Fresenius Medical Care AG
12.6. NxStage Medical, Inc.
12.7. Infomed SA
12.8. Medica SPA
12.9. Medites Pharma spol. s.r.o.
12.10. Quanta Dialysis Technologies Inc.(*LIST NOT EXHAUSTIVE)
13. APPENDIX
13.1. About Us and Services
13.2. Contact Us
LIST OF TABLES
Table 1 Global Continuous Renal Replacement Therapy Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)
Table 2 Global Continuous Renal Replacement Therapy Market Value, By Modality, 2023, 2027 & 2031 (US$ Million)
Table 3 Global Continuous Renal Replacement Therapy Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)
Table 4 Global Continuous Renal Replacement Therapy Market Value, By Region, 2023, 2027 & 2031 (US$ Million)
Table 5 Global Continuous Renal Replacement Therapy Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)
Table 6 Global Continuous Renal Replacement Therapy Market Value, By Product Type, 2022-2031 (US$ Million)
Table 7 Global Continuous Renal Replacement Therapy Market Value, By Modality, 2023, 2027 & 2031 (US$ Million)
Table 8 Global Continuous Renal Replacement Therapy Market Value, By Modality, 2022-2031 (US$ Million)
Table 9 Global Continuous Renal Replacement Therapy Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)
Table 10 Global Continuous Renal Replacement Therapy Market Value, By End-User, 2022-2031 (US$ Million)
Table 11 Global Continuous Renal Replacement Therapy Market Value, By Region, 2023, 2027 & 2031 (US$ Million)
Table 12 Global Continuous Renal Replacement Therapy Market Value, By Region, 2022-2031 (US$ Million)
Table 13 North America Continuous Renal Replacement Therapy Market Value, By Product Type, 2022-2031 (US$ Million)
Table 14 North America Continuous Renal Replacement Therapy Market Value, By Modality, 2022-2031 (US$ Million)
Table 15 North America Continuous Renal Replacement Therapy Market Value, By End-User, 2022-2031 (US$ Million)
Table 16 North America Continuous Renal Replacement Therapy Market Value, By Country, 2022-2031 (US$ Million)
Table 17 South America Continuous Renal Replacement Therapy Market Value, By Product Type, 2022-2031 (US$ Million)
Table 18 South America Continuous Renal Replacement Therapy Market Value, By Modality, 2022-2031 (US$ Million)
Table 19 South America Continuous Renal Replacement Therapy Market Value, By End-User, 2022-2031 (US$ Million)
Table 20 South America Continuous Renal Replacement Therapy Market Value, By Country, 2022-2031 (US$ Million)
Table 21 Europe Continuous Renal Replacement Therapy Market Value, By Product Type, 2022-2031 (US$ Million)
Table 22 Europe Continuous Renal Replacement Therapy Market Value, By Modality, 2022-2031 (US$ Million)
Table 23 Europe Continuous Renal Replacement Therapy Market Value, By End-User, 2022-2031 (US$ Million)
Table 24 Europe Continuous Renal Replacement Therapy Market Value, By Country, 2022-2031 (US$ Million)
Table 25 Asia-Pacific Continuous Renal Replacement Therapy Market Value, By Product Type, 2022-2031 (US$ Million)
Table 26 Asia-Pacific Continuous Renal Replacement Therapy Market Value, By Modality, 2022-2031 (US$ Million)
Table 27 Asia-Pacific Continuous Renal Replacement Therapy Market Value, By End-User, 2022-2031 (US$ Million)
Table 28 Asia-Pacific Continuous Renal Replacement Therapy Market Value, By Country, 2022-2031 (US$ Million)
Table 29 Middle East & Africa Continuous Renal Replacement Therapy Market Value, By Product Type, 2022-2031 (US$ Million)
Table 30 Middle East & Africa Continuous Renal Replacement Therapy Market Value, By Modality, 2022-2031 (US$ Million)
Table 31 Middle East & Africa Continuous Renal Replacement Therapy Market Value, By End-User, 2022-2031 (US$ Million)
Table 32 Baxter International Inc.: Overview
Table 33 Baxter International Inc.: Product Portfolio
Table 34 Baxter International Inc.: Key Developments
Table 35 Asahi Kasei Corporation: Overview
Table 36 Asahi Kasei Corporation: Product Portfolio
Table 37 Asahi Kasei Corporation: Key Developments
Table 38 B. Braun Medical Inc.: Overview
Table 39 B. Braun Medical Inc.: Product Portfolio
Table 40 B. Braun Medical Inc.: Key Developments
Table 41 Medtronic plc: Overview
Table 42 Medtronic plc: Product Portfolio
Table 43 Medtronic plc: Key Developments
Table 44 Fresenius Medical Care AG: Overview
Table 45 Fresenius Medical Care AG: Product Portfolio
Table 46 Fresenius Medical Care AG: Key Developments
Table 47 NxStage Medical, Inc.: Overview
Table 48 NxStage Medical, Inc.: Product Portfolio
Table 49 NxStage Medical, Inc.: Key Developments
Table 50 Infomed SA: Overview
Table 51 Infomed SA: Product Portfolio
Table 52 Infomed SA: Key Developments
Table 53 Medica SPA: Overview
Table 54 Medica SPA: Product Portfolio
Table 55 Medica SPA: Key Developments
Table 56 Medites Pharma spol. s.r.o.: Overview
Table 57 Medites Pharma spol. s.r.o.: Product Portfolio
Table 58 Medites Pharma spol. s.r.o.: Key Developments
Table 59 Quanta Dialysis Technologies Inc.: Overview
Table 60 Quanta Dialysis Technologies Inc.: Product Portfolio
Table 61 Quanta Dialysis Technologies Inc.: Key Developments
Table 1 Global Continuous Renal Replacement Therapy Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)
Table 2 Global Continuous Renal Replacement Therapy Market Value, By Modality, 2023, 2027 & 2031 (US$ Million)
Table 3 Global Continuous Renal Replacement Therapy Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)
Table 4 Global Continuous Renal Replacement Therapy Market Value, By Region, 2023, 2027 & 2031 (US$ Million)
Table 5 Global Continuous Renal Replacement Therapy Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)
Table 6 Global Continuous Renal Replacement Therapy Market Value, By Product Type, 2022-2031 (US$ Million)
Table 7 Global Continuous Renal Replacement Therapy Market Value, By Modality, 2023, 2027 & 2031 (US$ Million)
Table 8 Global Continuous Renal Replacement Therapy Market Value, By Modality, 2022-2031 (US$ Million)
Table 9 Global Continuous Renal Replacement Therapy Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)
Table 10 Global Continuous Renal Replacement Therapy Market Value, By End-User, 2022-2031 (US$ Million)
Table 11 Global Continuous Renal Replacement Therapy Market Value, By Region, 2023, 2027 & 2031 (US$ Million)
Table 12 Global Continuous Renal Replacement Therapy Market Value, By Region, 2022-2031 (US$ Million)
Table 13 North America Continuous Renal Replacement Therapy Market Value, By Product Type, 2022-2031 (US$ Million)
Table 14 North America Continuous Renal Replacement Therapy Market Value, By Modality, 2022-2031 (US$ Million)
Table 15 North America Continuous Renal Replacement Therapy Market Value, By End-User, 2022-2031 (US$ Million)
Table 16 North America Continuous Renal Replacement Therapy Market Value, By Country, 2022-2031 (US$ Million)
Table 17 South America Continuous Renal Replacement Therapy Market Value, By Product Type, 2022-2031 (US$ Million)
Table 18 South America Continuous Renal Replacement Therapy Market Value, By Modality, 2022-2031 (US$ Million)
Table 19 South America Continuous Renal Replacement Therapy Market Value, By End-User, 2022-2031 (US$ Million)
Table 20 South America Continuous Renal Replacement Therapy Market Value, By Country, 2022-2031 (US$ Million)
Table 21 Europe Continuous Renal Replacement Therapy Market Value, By Product Type, 2022-2031 (US$ Million)
Table 22 Europe Continuous Renal Replacement Therapy Market Value, By Modality, 2022-2031 (US$ Million)
Table 23 Europe Continuous Renal Replacement Therapy Market Value, By End-User, 2022-2031 (US$ Million)
Table 24 Europe Continuous Renal Replacement Therapy Market Value, By Country, 2022-2031 (US$ Million)
Table 25 Asia-Pacific Continuous Renal Replacement Therapy Market Value, By Product Type, 2022-2031 (US$ Million)
Table 26 Asia-Pacific Continuous Renal Replacement Therapy Market Value, By Modality, 2022-2031 (US$ Million)
Table 27 Asia-Pacific Continuous Renal Replacement Therapy Market Value, By End-User, 2022-2031 (US$ Million)
Table 28 Asia-Pacific Continuous Renal Replacement Therapy Market Value, By Country, 2022-2031 (US$ Million)
Table 29 Middle East & Africa Continuous Renal Replacement Therapy Market Value, By Product Type, 2022-2031 (US$ Million)
Table 30 Middle East & Africa Continuous Renal Replacement Therapy Market Value, By Modality, 2022-2031 (US$ Million)
Table 31 Middle East & Africa Continuous Renal Replacement Therapy Market Value, By End-User, 2022-2031 (US$ Million)
Table 32 Baxter International Inc.: Overview
Table 33 Baxter International Inc.: Product Portfolio
Table 34 Baxter International Inc.: Key Developments
Table 35 Asahi Kasei Corporation: Overview
Table 36 Asahi Kasei Corporation: Product Portfolio
Table 37 Asahi Kasei Corporation: Key Developments
Table 38 B. Braun Medical Inc.: Overview
Table 39 B. Braun Medical Inc.: Product Portfolio
Table 40 B. Braun Medical Inc.: Key Developments
Table 41 Medtronic plc: Overview
Table 42 Medtronic plc: Product Portfolio
Table 43 Medtronic plc: Key Developments
Table 44 Fresenius Medical Care AG: Overview
Table 45 Fresenius Medical Care AG: Product Portfolio
Table 46 Fresenius Medical Care AG: Key Developments
Table 47 NxStage Medical, Inc.: Overview
Table 48 NxStage Medical, Inc.: Product Portfolio
Table 49 NxStage Medical, Inc.: Key Developments
Table 50 Infomed SA: Overview
Table 51 Infomed SA: Product Portfolio
Table 52 Infomed SA: Key Developments
Table 53 Medica SPA: Overview
Table 54 Medica SPA: Product Portfolio
Table 55 Medica SPA: Key Developments
Table 56 Medites Pharma spol. s.r.o.: Overview
Table 57 Medites Pharma spol. s.r.o.: Product Portfolio
Table 58 Medites Pharma spol. s.r.o.: Key Developments
Table 59 Quanta Dialysis Technologies Inc.: Overview
Table 60 Quanta Dialysis Technologies Inc.: Product Portfolio
Table 61 Quanta Dialysis Technologies Inc.: Key Developments
LIST OF FIGURES
Figure 1 Global Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 2 Global Continuous Renal Replacement Therapy Market Share, By Product Type, 2022 & 2031 (%)
Figure 3 Global Continuous Renal Replacement Therapy Market Share, By Modality, 2022 & 2031 (%)
Figure 4 Global Continuous Renal Replacement Therapy Market Share, By End-User, 2022 & 2031 (%)
Figure 5 Global Continuous Renal Replacement Therapy Market Share, By Region, 2022 & 2031 (%)
Figure 6 Global Continuous Renal Replacement Therapy Market Y-o-Y Growth, By Product Type, 2022-2031 (%)
Figure 7 Consumables Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 8 CRRT Machines and Systems Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 9 Accessories Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 10 Global Continuous Renal Replacement Therapy Market Y-o-Y Growth, By Modality, 2022-2031 (%)
Figure 11 Continuous Venovenous Hemofiltration (CVVH) Modality in Global Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 12 Continuous Venovenous Hemodialysis (CVVHD) Modality in Global Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 13 Continuous Venovenous Hemodiafiltration (CVVHDF) Modality in Global Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 14 Global Continuous Renal Replacement Therapy Market Y-o-Y Growth, By End-User, 2022-2031 (%)
Figure 15 Hospitals End-User in Global Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 16 Specialty Clinics End-User in Global Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 17 Ambulatory Surgical Centers End-User in Global Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 18 Homecare Settings End-User in Global Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 19 Others End-User in Global Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 20 Global Continuous Renal Replacement Therapy Market Y-o-Y Growth, By Region, 2022-2031 (%)
Figure 21 North America Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 22 Asia-Pacific Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 23 Europe Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 24 South America Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 25 Middle East and Africa Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 26 North America Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 27 North America Continuous Renal Replacement Therapy Market Share, By Product Type, 2022 & 2031 (%)
Figure 28 North America Continuous Renal Replacement Therapy Market Share, By Modality, 2022 & 2031 (%)
Figure 29 North America Continuous Renal Replacement Therapy Market Share, By End-User, 2022 & 2031 (%)
Figure 30 North America Continuous Renal Replacement Therapy Market Share, By Country, 2022 & 2031 (%)
Figure 31 South America Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 32 South America Continuous Renal Replacement Therapy Market Share, By Product Type, 2022 & 2031 (%)
Figure 33 South America Continuous Renal Replacement Therapy Market Share, By Modality, 2022 & 2031 (%)
Figure 34 South America Continuous Renal Replacement Therapy Market Share, By End-User, 2022 & 2031 (%)
Figure 35 South America Continuous Renal Replacement Therapy Market Share, By Country, 2022 & 2031 (%)
Figure 36 Europe Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 37 Europe Continuous Renal Replacement Therapy Market Share, By Product Type, 2022 & 2031 (%)
Figure 38 Europe Continuous Renal Replacement Therapy Market Share, By Modality, 2022 & 2031 (%)
Figure 39 Europe Continuous Renal Replacement Therapy Market Share, By End-User, 2022 & 2031 (%)
Figure 40 Europe Continuous Renal Replacement Therapy Market Share, By Country, 2022 & 2031 (%)
Figure 41 Asia-Pacific Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 42 Asia-Pacific Continuous Renal Replacement Therapy Market Share, By Product Type, 2022 & 2031 (%)
Figure 43 Asia-Pacific Continuous Renal Replacement Therapy Market Share, By Modality, 2022 & 2031 (%)
Figure 44 Asia-Pacific Continuous Renal Replacement Therapy Market Share, By End-User, 2022 & 2031 (%)
Figure 45 Asia-Pacific Continuous Renal Replacement Therapy Market Share, By Country, 2022 & 2031 (%)
Figure 46 Middle East & Africa Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 47 Middle East & Africa Continuous Renal Replacement Therapy Market Share, By Product Type, 2022 & 2031 (%)
Figure 48 Middle East & Africa Continuous Renal Replacement Therapy Market Share, By Modality, 2022 & 2031 (%)
Figure 49 Middle East & Africa Continuous Renal Replacement Therapy Market Share, By End-User, 2022 & 2031 (%)
Figure 50 Baxter International Inc.: Financials
Figure 51 Asahi Kasei Corporation: Financials
Figure 52 B. Braun Medical Inc.: Financials
Figure 53 Medtronic plc: Financials
Figure 54 Fresenius Medical Care AG: Financials
Figure 55 NxStage Medical, Inc.: Financials
Figure 56 Infomed SA: Financials
Figure 57 Medica SPA: Financials
Figure 58 Medites Pharma spol. s.r.o.: Financials
Figure 59 Quanta Dialysis Technologies Inc.: Financials
Figure 1 Global Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 2 Global Continuous Renal Replacement Therapy Market Share, By Product Type, 2022 & 2031 (%)
Figure 3 Global Continuous Renal Replacement Therapy Market Share, By Modality, 2022 & 2031 (%)
Figure 4 Global Continuous Renal Replacement Therapy Market Share, By End-User, 2022 & 2031 (%)
Figure 5 Global Continuous Renal Replacement Therapy Market Share, By Region, 2022 & 2031 (%)
Figure 6 Global Continuous Renal Replacement Therapy Market Y-o-Y Growth, By Product Type, 2022-2031 (%)
Figure 7 Consumables Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 8 CRRT Machines and Systems Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 9 Accessories Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 10 Global Continuous Renal Replacement Therapy Market Y-o-Y Growth, By Modality, 2022-2031 (%)
Figure 11 Continuous Venovenous Hemofiltration (CVVH) Modality in Global Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 12 Continuous Venovenous Hemodialysis (CVVHD) Modality in Global Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 13 Continuous Venovenous Hemodiafiltration (CVVHDF) Modality in Global Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 14 Global Continuous Renal Replacement Therapy Market Y-o-Y Growth, By End-User, 2022-2031 (%)
Figure 15 Hospitals End-User in Global Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 16 Specialty Clinics End-User in Global Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 17 Ambulatory Surgical Centers End-User in Global Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 18 Homecare Settings End-User in Global Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 19 Others End-User in Global Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 20 Global Continuous Renal Replacement Therapy Market Y-o-Y Growth, By Region, 2022-2031 (%)
Figure 21 North America Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 22 Asia-Pacific Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 23 Europe Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 24 South America Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 25 Middle East and Africa Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 26 North America Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 27 North America Continuous Renal Replacement Therapy Market Share, By Product Type, 2022 & 2031 (%)
Figure 28 North America Continuous Renal Replacement Therapy Market Share, By Modality, 2022 & 2031 (%)
Figure 29 North America Continuous Renal Replacement Therapy Market Share, By End-User, 2022 & 2031 (%)
Figure 30 North America Continuous Renal Replacement Therapy Market Share, By Country, 2022 & 2031 (%)
Figure 31 South America Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 32 South America Continuous Renal Replacement Therapy Market Share, By Product Type, 2022 & 2031 (%)
Figure 33 South America Continuous Renal Replacement Therapy Market Share, By Modality, 2022 & 2031 (%)
Figure 34 South America Continuous Renal Replacement Therapy Market Share, By End-User, 2022 & 2031 (%)
Figure 35 South America Continuous Renal Replacement Therapy Market Share, By Country, 2022 & 2031 (%)
Figure 36 Europe Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 37 Europe Continuous Renal Replacement Therapy Market Share, By Product Type, 2022 & 2031 (%)
Figure 38 Europe Continuous Renal Replacement Therapy Market Share, By Modality, 2022 & 2031 (%)
Figure 39 Europe Continuous Renal Replacement Therapy Market Share, By End-User, 2022 & 2031 (%)
Figure 40 Europe Continuous Renal Replacement Therapy Market Share, By Country, 2022 & 2031 (%)
Figure 41 Asia-Pacific Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 42 Asia-Pacific Continuous Renal Replacement Therapy Market Share, By Product Type, 2022 & 2031 (%)
Figure 43 Asia-Pacific Continuous Renal Replacement Therapy Market Share, By Modality, 2022 & 2031 (%)
Figure 44 Asia-Pacific Continuous Renal Replacement Therapy Market Share, By End-User, 2022 & 2031 (%)
Figure 45 Asia-Pacific Continuous Renal Replacement Therapy Market Share, By Country, 2022 & 2031 (%)
Figure 46 Middle East & Africa Continuous Renal Replacement Therapy Market Value, 2022-2031 (US$ Million)
Figure 47 Middle East & Africa Continuous Renal Replacement Therapy Market Share, By Product Type, 2022 & 2031 (%)
Figure 48 Middle East & Africa Continuous Renal Replacement Therapy Market Share, By Modality, 2022 & 2031 (%)
Figure 49 Middle East & Africa Continuous Renal Replacement Therapy Market Share, By End-User, 2022 & 2031 (%)
Figure 50 Baxter International Inc.: Financials
Figure 51 Asahi Kasei Corporation: Financials
Figure 52 B. Braun Medical Inc.: Financials
Figure 53 Medtronic plc: Financials
Figure 54 Fresenius Medical Care AG: Financials
Figure 55 NxStage Medical, Inc.: Financials
Figure 56 Infomed SA: Financials
Figure 57 Medica SPA: Financials
Figure 58 Medites Pharma spol. s.r.o.: Financials
Figure 59 Quanta Dialysis Technologies Inc.: Financials
